This is the fourth article in a series of five blog posts that are putting ADCs in the spotlight. This article will describe the origins of and obstacles faced during ADCs development from the beginning of the 20th century to today. Please read the introductory post āADCs: What are they and why do they matter?ā before this post, if you are unfamiliar with ADCs. Look out for āADCs: Pipeline & Progressā.
Batch Manufacturing
Available for chemotherapy, centralised intravenous additives service (CIVAS) and patient-controlled analgesia (PCA).
PS Manufacturing
Our Named Patient service is available for Chemotherapy, CIVAS and PCA, tailored to yours and patientās individual requirements.
Extended Stability
Bath ASUās aseptic compounding service offers you a wide range of products with extended shelf-life.